Transcriptional regulation of the human reduced folate carrier A1/A2 promoter: Identification of critical roles for the USF and GATA families of transcription factors

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1731, Issue 2, 2005, Pages 115-124

  Payton, Scott G ^a   Liu, Mingjun ^a   Ge, Yubin ^a   Matherly, Larry H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GATA; Methotrexate; Reduced folate carrier; Transcription; USF

Indexed keywords

REDUCED FOLATE CARRIER; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; UPSTREAM STIMULATORY FACTOR 1;

ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; DROSOPHILA; EXON; GENE ACTIVATION; GENE CONSTRUCT; GENE DELETION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INSECT CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RNA SPLICING; TRANSCRIPTION REGULATION;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DNA-BINDING PROTEINS; DROSOPHILA; E-BOX ELEMENTS; EXONS; GATA TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; MEMBRANE TRANSPORT PROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; UPSTREAM STIMULATORY FACTORS;

ANIMALIA; INSECTA;

EID: 28244478028     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2005.08.010     Document Type: Article

References (33)

1. L.H. Matherly, and I.D. Goldman Membrane transport of folates Vitam. Horm. 66 2003 403 456
2. J.R. Whetstine, R.M. Flatley, and L.H. Matherly The human reduced folate carrier gene is ubiquitously and differently expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter Biochem. J. 367 2002 629 640
3. M. Lucock Folic acid: nutritional biochemistry, molecular biology, and role in disease processes Mol. Genet. Metabol. 71 2000 121 138
4. L.H. Matherly Human reduced folate carrier gene and transcript variants: functional, physiologic, and pharmacologic consequences Curr. Pharmacogenetics 2 2004 287 298
5. I.D. Goldman, and L.H. Matherly The cellular pharmacology of methotrexate Pharmacol. Ther. 28 1985 77 100
6. I.D. Goldman, and R. Zhao Molecular, biochemical, and cellular pharmacology of pemetrexed Semin. Oncol. 29 2002 3 17
7. R. Zhao, and I.D. Goldman Resistance to antifolates Oncogene 22 2003 7431 7457
8. J. Jolivet, K.H. Cowan, G.A. Curt, N.J. Clendenin, and B.A. Chabner The pharmacology and clinical use of methotrexate N. Engl. J. Med. 309 1983 1094 1104
9. R.A. Messmann, and C.J. Allegra Antifolates B.A. Chabner D.L. Longo Cancer Chemotherapy and Biotherapy 3rd ed. 2001 Lippincott-Raven Philadelphia 139 184
10. L. Zhang, J.W. Taub, M. Williamson, S.C. Wong, B. Hukku, J. Pullen, Y. Ravindranath, and L.H. Matherly Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy Clin. Cancer Res. 4 1998 2169 2177
11. R.M. Flatley, S.G. Payton, J.W. Taub, and L.H. Matherly Primary acute lymphoblastic leukemia cells use a novel promoter and 5′non-coding exon for the human reduced folate carrier that encodes a modified carrier translated from an upstream translational start Clin. Cancer Res. 10 2004 5111 5222
12. R. Gorlick, E. Goker, T. Trippett, P. Steinherz, Y. Elisseyeff, M. Mazumdar, W.F. Flintoff, and J.R. Bertino Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression Blood 89 1997 1013 1018
13. W. Guo, J.H. Healey, P.A. Meyers, M. Ladanyi, A.G. Huvos, J.R. Bertino, and R. Gorlick Mechanisms of methotrexate resistance in osteosarcoma Clin. Cancer Res. 5 1999 621 627
14. J.R. Whetstine, T.L. Witt, and L.H. Matherly The human reduced folate carrier gene is regulated by the AP2 and Sp1 transcription factor families and a 61 base pair polymorphism J. Biol. Chem. 277 2002 43800 43873
15. M. Liu, J.R. Whetstine, S.G. Payton, Y. Ge, R.M. Flatley, and L.H. Matherly Roles of USF, Ikaros, and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter Biochem. J. 383 2004 249 257
16. S.G. Payton, J.R. Whetstine, Y. Ge, and L.H. Matherly Transcriptional regulation of the human reduced folate carrier promoter C: synergistic transactivation by Sp1 and E/EBP beta and identification of a downstream repressor Biochim. Biophys. Acta 1727 2005 45 47
17. T.A.Y. Ayoubi, and W.J.M. Van de Ven Regulation of gene expression by alternative promoters FASEB J. 10 1996 453 460
18. Y. Ge, T.L. Jensen, L.H. Matherly, and J.W. Taub Functional interactions between USF1/USF2a and Sp1 are required to regulate human deoxycytidine kinase promoter activity J. Biol. Chem. 278 2003 49901 49910
19. Y. Ge, T.L. Jensen, M.L. Stout, R.M. Flatley, P. Grohar, Y. Ravindranath, L.H. Matherly, and J.W. Taub The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines Cancer Res. 64 2004 728 735
20. Y. Ge, M.L. Stout, D.A. Tatman, T.L. Jensen, S. Buck, R.L. Thomas, Y. Ravindranath, L.H. Matherly, and J.W. Taub GATA1, cytidine deaminase, and the high cure rate of down syndrome children with acute megakaryocytic leukemia J. Natl. Cancer Inst. 97 2005 226 231
21. L. Zhang, S.C. Wong, and L.H. Matherly Structure and organization of the human reduced folate carrier gene Biochim. Biophys. Acta 1442 1998 389 393
22. R.M. Horton, Z.L. Cai, S.N. Ho, and L.R. Pease Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction Biotechniques 8 1990 528 535
23. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
24. P. Matsudaira Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes J. Biol. Chem. 262 1987 10035 10038
25. F.M. Ausuble, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl Current Protocols in Molecular Biology vol. 12 1998 John Wiley and Sons, Inc. New York 1.1 12.1.9
26. C. Grandori, S.M. Cowley, L.P. James, and R.N. Eisenman The Myc/Max/Mad network and the transcriptional control of cell behavior Annu. Rev. Cell Dev. Biol. 16 2000 653 699
27. S.H. Orkin GATA-binding transcription factors in hematopoietic cells Blood 80 1992 575 581
28. A.B. Cantor, and S.H. Orkin Transcriptional regulation of erythropoiesis: an affair involving multiple partners Oncogene 21 2002 3368 3376
29. R. Shimizu, T. Kuroha, O. Ohneda, X. Pan, K. Ohneda, S. Takahashi, S. Philipsen, and M. Yamamoto Leukemogenesis caused by incapacitated GATA1 function Mol. Cell. Biol. 24 2004 10814 10825
30. A.W. Moore, S. Barbel, L.Y. Jan, and Y.N. Jan A genomewide survey of basic helix-loop-helix factors in Drosophila Proc. Natl. Acad. Sci. 97 2000 10436 10441
31. J. Worm, A.F. Kirkin, K.N. Dzhandzhugazyan, and P. Guldberg Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells J. Biol. Chem. 276 2001 39990 40000
32. A.J. Ferreri, S. Dell'Oro, D. Capello, M. Ponzoni, P. Luzzolino, D. Rossi, F. Pasini, A. Ambrosetti, E. Orvieto, F. Ferrarese, G. Arrigoni, M. Foppoli, M. Reni, and G. Gaidano Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas Br. J. Haematol. 126 2004 657 664
33. M. Liu, Y. Ge, D.C. Cabelof, A. Aboukameel, A.R. Heydari, R. Mohammad, and L.H. Matherly Structure and regulation of the murine reduced folate carrier gene: identification of 4 non-coding exons and promoters and regulation by dietary folates J. Biol. Chem. 280 2005 5588 5597